GS Mortgage Securities Trust 2021-GSA3 has filed an ABS-EE, providing an update on its commercial mortgage-backed securities. This filing is significant as it reflects ongoing activity and performance in the asset-backed securities market, particularly in the commercial mortgage sector.
Background
GS Mortgage Securities Trust 2021-GSA3 is classified under the SIC code 6189, which pertains to Asset-Backed Securities. The company operates in the financial sector, focusing on securitization of commercial mortgages. Recent filings include a 10-D and an ABS-EE, both submitted on October 27, 2026, with accession number 0001888524-26-019090.
What the Filing Says
The filing states that the report period spans from September 12, 2026, to October 13, 2026, and includes asset data related to commercial mortgages. It highlights the performance of various properties and their financial metrics, including original loan amounts and interest rates. The filing notes, "The depositor has duly caused this Form to be signed on its behalf by the undersigned hereunto duly authorized," indicating compliance with regulatory requirements.
Impact
This update may affect investors and stakeholders in the asset-backed securities sector, particularly those focused on commercial mortgages. The filing includes details about the performance of specific properties, such as occupancy rates and revenue figures, which are crucial for assessing the health of the underlying assets. Competitors mentioned in the filing include Goldman Sachs Mortgage Company, Argentic Real Estate Finance LLC, and Starwood Mortgage Capital LLC, all of which are active in the same market.
What's Next
The filing does not say what happens next, but it is expected that further updates will follow as the company continues to monitor and report on the performance of its assets.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










